vs
卡彭特科技（CRS）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
卡彭特科技的季度营收约是Healthpeak Properties的1.1倍（$811.5M vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 17.2%，领先56.0%），卡彭特科技同比增速更快（11.6% vs 3.1%），Healthpeak Properties自由现金流更多（$357.0M vs $124.8M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 0.8%）
卡彭特科技是全球特种合金材料供应商，主营不锈钢、耐腐蚀镍、铜、钛合金及3D增材制造用粉末合金的研发、生产与分销。2018财年其营收分布为：航空航天与国防占55%，工业与消费品占17%，医疗占8%，交通、能源各占7%，分销业务占6%。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CRS vs DOC — 直观对比
营收规模更大
CRS
是对方的1.1倍
$719.4M
营收增速更快
CRS
高出8.6%
3.1%
净利率更高
DOC
高出56.0%
17.2%
自由现金流更多
DOC
多$232.2M
$124.8M
两年增速更快
DOC
近两年复合增速
0.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $811.5M | $719.4M |
| 净利润 | $139.6M | $114.0M |
| 毛利率 | 31.0% | — |
| 营业利润率 | 23.0% | 17.4% |
| 净利率 | 17.2% | 73.2% |
| 营收同比 | 11.6% | 3.1% |
| 净利润同比 | 46.3% | 2406.4% |
| 每股收益（稀释后） | $2.77 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRSDOC
| Q1 26 | $811.5M | — | ||
| Q4 25 | $728.0M | $719.4M | ||
| Q3 25 | $733.7M | $705.9M | ||
| Q2 25 | $755.6M | $694.3M | ||
| Q1 25 | $727.0M | $702.9M | ||
| Q4 24 | $676.9M | $698.0M | ||
| Q3 24 | $717.6M | $700.4M | ||
| Q2 24 | $798.7M | $695.5M |
净利润CRSDOC
| Q1 26 | $139.6M | — | ||
| Q4 25 | $105.3M | $114.0M | ||
| Q3 25 | $122.5M | $-117.1M | ||
| Q2 25 | $111.7M | $31.7M | ||
| Q1 25 | $95.4M | $42.8M | ||
| Q4 24 | $84.1M | $4.5M | ||
| Q3 24 | $84.8M | $85.9M | ||
| Q2 24 | $93.6M | $146.0M |
毛利率CRSDOC
| Q1 26 | 31.0% | — | ||
| Q4 25 | 30.0% | — | ||
| Q3 25 | 29.5% | 58.6% | ||
| Q2 25 | 28.3% | 60.2% | ||
| Q1 25 | 27.6% | 61.1% | ||
| Q4 24 | 26.2% | 60.3% | ||
| Q3 24 | 24.6% | 60.0% | ||
| Q2 24 | 23.9% | 60.6% |
营业利润率CRSDOC
| Q1 26 | 23.0% | — | ||
| Q4 25 | 21.3% | 17.4% | ||
| Q3 25 | 20.9% | 9.2% | ||
| Q2 25 | 20.1% | 5.7% | ||
| Q1 25 | 19.0% | 7.7% | ||
| Q4 24 | 17.6% | -2.2% | ||
| Q3 24 | 15.8% | 14.1% | ||
| Q2 24 | 13.6% | 22.3% |
净利率CRSDOC
| Q1 26 | 17.2% | — | ||
| Q4 25 | 14.5% | 73.2% | ||
| Q3 25 | 16.7% | -16.6% | ||
| Q2 25 | 14.8% | 4.6% | ||
| Q1 25 | 13.1% | 6.1% | ||
| Q4 24 | 12.4% | 0.7% | ||
| Q3 24 | 11.8% | 12.3% | ||
| Q2 24 | 11.7% | 21.0% |
每股收益（稀释后）CRSDOC
| Q1 26 | $2.77 | — | ||
| Q4 25 | $2.09 | $0.16 | ||
| Q3 25 | $2.43 | $-0.17 | ||
| Q2 25 | $2.21 | $0.05 | ||
| Q1 25 | $1.88 | $0.06 | ||
| Q4 24 | $1.66 | $0.02 | ||
| Q3 24 | $1.67 | $0.12 | ||
| Q2 24 | $1.85 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $294.8M | $467.5M |
| 总债务越低越好 | $690.4M | $9.8B |
| 股东权益账面价值 | $2.1B | $7.5B |
| 总资产 | $3.7B | $20.3B |
| 负债/权益比越低杠杆越低 | 0.33× | 1.31× |
8季度趋势，按日历期对齐
现金及短期投资CRSDOC
| Q1 26 | $294.8M | — | ||
| Q4 25 | $231.9M | $467.5M | ||
| Q3 25 | $208.0M | $91.0M | ||
| Q2 25 | $315.5M | $89.4M | ||
| Q1 25 | $151.5M | $70.6M | ||
| Q4 24 | $162.1M | $119.8M | ||
| Q3 24 | $150.2M | $180.4M | ||
| Q2 24 | $199.1M | $106.9M |
总债务CRSDOC
| Q1 26 | $690.4M | — | ||
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B |
股东权益CRSDOC
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.0B | $7.5B | ||
| Q3 25 | $1.9B | $7.6B | ||
| Q2 25 | $1.9B | $7.9B | ||
| Q1 25 | $1.8B | $8.2B | ||
| Q4 24 | $1.7B | $8.4B | ||
| Q3 24 | $1.7B | $8.6B | ||
| Q2 24 | $1.6B | $8.8B |
总资产CRSDOC
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.5B | $20.3B | ||
| Q3 25 | $3.4B | $19.6B | ||
| Q2 25 | $3.5B | $19.8B | ||
| Q1 25 | $3.4B | $19.8B | ||
| Q4 24 | $3.3B | $19.9B | ||
| Q3 24 | $3.3B | $20.0B | ||
| Q2 24 | $3.3B | $20.2B |
负债/权益比CRSDOC
| Q1 26 | 0.33× | — | ||
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $124.8M | $357.0M |
| 自由现金流率自由现金流/营收 | 15.4% | 49.6% |
| 资本支出强度资本支出/营收 | — | 124.4% |
| 现金转化率经营现金流/净利润 | — | 10.99× |
| 过去12个月自由现金流最近4个季度 | $407.5M | — |
8季度趋势，按日历期对齐
经营现金流CRSDOC
| Q1 26 | — | — | ||
| Q4 25 | $132.2M | $1.3B | ||
| Q3 25 | $39.2M | $315.0M | ||
| Q2 25 | $258.1M | $363.5M | ||
| Q1 25 | $74.2M | $279.4M | ||
| Q4 24 | $67.9M | $1.1B | ||
| Q3 24 | $40.2M | $318.2M | ||
| Q2 24 | $169.5M | $316.2M |
自由现金流CRSDOC
| Q1 26 | $124.8M | — | ||
| Q4 25 | $85.9M | $357.0M | ||
| Q3 25 | $-3.4M | — | ||
| Q2 25 | $200.2M | — | ||
| Q1 25 | $34.0M | — | ||
| Q4 24 | $38.6M | $333.7M | ||
| Q3 24 | $13.3M | — | ||
| Q2 24 | $141.8M | — |
自由现金流率CRSDOC
| Q1 26 | 15.4% | — | ||
| Q4 25 | 11.8% | 49.6% | ||
| Q3 25 | -0.5% | — | ||
| Q2 25 | 26.5% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 5.7% | 47.8% | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 17.8% | — |
资本支出强度CRSDOC
| Q1 26 | — | — | ||
| Q4 25 | 6.4% | 124.4% | ||
| Q3 25 | 5.8% | — | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 4.3% | 105.6% | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 3.5% | — |
现金转化率CRSDOC
| Q1 26 | — | — | ||
| Q4 25 | 1.26× | 10.99× | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | 2.31× | 11.48× | ||
| Q1 25 | 0.78× | 6.52× | ||
| Q4 24 | 0.81× | 235.43× | ||
| Q3 24 | 0.47× | 3.71× | ||
| Q2 24 | 1.81× | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRS
| Aerospace and Defense | $435.6M | 54% |
| Surcharge revenue | $155.9M | 19% |
| Industrial and Consumer | $78.1M | 10% |
| Medical | $51.7M | 6% |
| Energy | $50.5M | 6% |
| Distribution | $20.4M | 3% |
| Transportation | $19.3M | 2% |
DOC
暂无分部数据
